Sorted By:

Relevance


Mental health in the New Era of Medicine

PhRMA  |  Blog Post

To learn more about the positive impact of the work being done by America’s biopharmaceutical companies, visit www.innovation.org.  
http://catalyst.phrma.org/mental-health-in-the-new-era-of-medicine

Average Net Brand Price Growth Declined as a Result of Increased Rebates

Chartpack  |  From Our Network

...
http://chartpack.phrma.org/2016-perspective/chapter-5/average-net-brand-price-growth-declined-as-a-result-of-increased-rebates

PhRMA CEO talks White House meeting, innovation & jobs with POLITICO’s Pulse Check

PhRMA  |  Blog Post

Listen to the full interview here, and visit .com/?
http://catalyst.phrma.org/phrma-ceo-talks-white-house-meeting-innovation-jobs-with-politicos-pulse-check

Alzheimer's Webinar - July 15, 2015 at 1:30 pm EDT

PhRMA  |  Video

  New Report: Alzheimer’s Research “Setbacks” Critical for Breakthroughs of TomorrowRead PhRMA's Press Release on the Summer 2015 report
http://www.phrma.org/video/alzheimer-s-webinar-july-15-2015-at-1-30-pm-edt

PhRMA CEO Statement Following Meeting With President Trump

PhRMA  |  Blog Post


http://catalyst.phrma.org/phrma-ceo-statement-following-meeting-with-president-trump

New non-discrimination rule neglects to define discriminatory benefits

PhRMA  |  Blog Post

Med. 399, 401 (2015), available at http://www.nejm.org/doi/pdf/10.1056/NEJMp1411376.
http://catalyst.phrma.org/new-non-discrimination-rule-neglects-to-define-discriminatory-benefits

Why Do More Black Women Die of Breast Cancer? A Study Aims To Find Out

From Hope To Cures  |  From Our Network

“If you can identify who’s likely to get it, you may be able to develop a targeted way to identify them and get them the care that they need,” Dr.
http://www.fromhopetocures.org/why-do-more-black-women-die-of-breast-cancer-a-study-aims-to-find-out

New Spanish-language resources added to ABCs En Español

PhRMA  |  Blog Post

Learn more about how we can better engage and empower patients, and visit AccessBetterCoverage.org for other English-language resources.
http://catalyst.phrma.org/new-spanish-language-resources-added-to-abcs-en-español

The Biopharmaceutical Industry Invests More R&D Dollars per Employee Than Any Other Industry

Chartpack  |  From Our Network

...
http://chartpack.phrma.org/2016-perspective/chapter-7/the-biopharmaceutical-industry-invests-more-randd-dollars-per-employee-than-any-other-industry

Medicare Monday: New research finds drugs not a key driver of Medicare Part B costs

PhRMA  |  Blog Post

Learn more at PhRMA.org/Cost and check back with us on Medicare Monday.
http://catalyst.phrma.org/medicare-monday-new-research-finds-drugs-not-a-key-driver-of-medicare-part-b-costs

Are new hep C treatments cost effective? Doctors say answer is “a resounding yes”

PhRMA  |  Blog Post

The answer is yes.
http://catalyst.phrma.org/are-new-hep-c-treatments-cost-effective-doctors-say-answer-is-a-resounding-yes

New report confirms competitive market works; Net prices for medicines increased just 2.8 percent in 2015

PhRMA  |  Blog Post

Read more on how the competitive biopharmaceutical market controls costs and encourages the development of new treatments and cures at www.phrma.org/cost.
http://catalyst.phrma.org/new-report-confirms-competitive-market-works-net-prices-for-medicines-increased-just-2.8-percent-in-2015

UK Cancer Patients Face Increasing Coverage Restrictions Due to Centralized Cost-Effectiveness Standard, New Report Shows

PhRMA  |  Press Release

Since 2000, PhRMA member companies have invested more than $550 billion in the search for new treatments and cures, including an estimated $51.1 billion in 2013 alone.
http://www.phrma.org/press-release/uk-cancer-patients-face-increasing-coverage-restrictions-due-to-centralized-cost-effectiveness-standard-new-report-shows

Medicare Monday: What does Medicare Part B Cover?

PhRMA  |  Blog Post

Check back with Medicare Monday for more on Part B and other aspects of Medicare next week.
http://catalyst.phrma.org/medicare-monday-what-does-medicare-part-b-cover

PhRMA Statement on the Passing of Sen. Ted Kennedy

PhRMA  |  Press Release

PhRMA members alone invested an estimated $50.3 billion in 2008 in discovering and developing new medicines.
http://www.phrma.org/press-release/phrma-statement-on-the-passing-of-sen-ted-kennedy

New report provides recommendations for securing and protecting IP

PhRMA  |  Blog Post

Without the security of a strong IP system, biopharmaceutical researchers may not have the ability to explore new areas of medical innovation and unearth the findings that will lead to the treatments of tomorrow.
http://catalyst.phrma.org/new-report-provides-recommendations-for-securing-and-protecting-ip

Innovative Oncology Medicines Have Led to Impressive Gains in Patient Survivorship

PhRMA  |  Press Release

“With more than 5,000 medicines in the biopharmaceutical pipeline, including more than 3,000 potential medicines for cancer patients, the future looks bright for continued progress.
http://www.phrma.org/press-release/innovative-oncology-medicines-have-led-to-impressive-gains-in-patient-survivorship

Where'd My Discount Go?

PhRMA  |  Graphic

Learn more at PhRMA.org/discounts.
http://www.phrma.org/where-did-my-discount-go

Celebrating cardiovascular health on World Heart Day 2015

PhRMA  |  Blog Post

As we celebrate World Heart Day, it is important to remember the role of continued innovation in reducing the impact of heart disease and helping patients live longer, healthier lives.
http://catalyst.phrma.org/celebrating-cardiovascular-health-on-world-heart-day-2015

Medicare Monday: Did you know Medicare Part B uses a market-based system to pay for medicines?

PhRMA  |  Blog Post

Learn more about Medicare Part B at PhRMA.org/PartB.
http://catalyst.phrma.org/medicare-monday-did-you-know-medicare-part-b-uses-a-market-based-system-to-pay-for-medicines

Aspen Spotlight Health 360° VIDEO PREMIERE:
New Virtual Reality Video Takes You Inside The Lab with Researchers to Showcase Amazing Advancements in Medicine

PhRMA  |  Press Release

Since 2000, PhRMA member companies have invested more than half a trillion dollars in the search for new treatments and cures, including an estimated $58.8 billion in 2015 alone.
http://www.phrma.org

Medicare Monday: Did You Know Four out of Five Part D Prescriptions Are Generic?

PhRMA  |  Blog Post


http://catalyst.phrma.org/medicaremonday-did-you-know-four-out-of-five-part-d-prescriptions-are-generic

Strong R&D Investment the Best Bet to Slow Alzheimer’s Growing Threat

PhRMA  |  Blog Post

Building on these “failures,” researchers today are studying more than 80 medicines in development, to identify better treatments for patients.
http://catalyst.phrma.org/strong-rd-investment-the-best-bet-to-slow-alzheimers-growing-threat

Modernizing FDA regulations to advance a value-driven health care system

PhRMA  |  Blog Post

public hearing, or see the .regulations.gov/document?
http://catalyst.phrma.org/modernizing-fda-regulations-to-advance-a-value-driven-health-care-system

ICYMI: The New Era of Medicine initiative spotlights genomics in NYC

PhRMA  |  Blog Post

Genomics technologies have allowed us to design rapid response platform technologies: those could be our best bet for the rapid production and scale up of a new vaccine.” - Ripley Ballou, Vice President of Vaccines, GSK Click here to watch the full video and learn more at innovation.org
http://catalyst.phrma.org/icymi-the-new-era-of-medicine-initiative-spotlights-genomics-in-nyc

You have reviewed the first 75 results out of 1960. Each page contains 25 results. You're on page 3.

prev 1 2 3 4 5 6 next